1. Israel Stocks

  2. •

    Health technology

  3. •

    Biotechnology
IBI SILVER CASTLE LTD

IBI SILVER CASTLE LTD

TTASE:IBIS-M
3,721.00
ILA
+321.00
(+9.44%)
1.41BMarket Cap
IBI SILVER CASTLE LTD
TASE:IBIS-M
(Tel Aviv Stock Exchange)

Recent

price

3,721.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
ILS
0.47
219.15
298.94
13.4
6.64
4.43
4.59
2.88
22.81
229.5
0.43
16.38
18.85
4.04
- -
Revenue per Share
-143.38
-611.19
-401.79
-319.93
-266.6
-253.32
-158.28
-242.98
-83.23
-576.41
-21.41
-35.1
-32.86
-28.15
- -
Basic EPS, GAAP
-173.74
-537.81
-517.2
-282.58
-273.17
-219.29
-221.54
-160.38
-60.1
-408.6
-6.61
-22.9
-17.8
-6.81
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
323.82
234.44
400.29
131.81
-116.67
512.66
71.64
12.54
14.27
-14.53
-31.97
1.81
-19.64
-4.86
Book Value per Share
- -
145.97
140.74
362.29
109.54
-116.67
512.66
71.64
12.54
14.27
-14.53
-31.97
1.81
-19.64
-4.86
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
1
2
- -
- -
- -
- -
- -
1
2
1
3
5
1
- -
Sales/Revenue/Turnover
-28,807.14
-298.41
-130.92
-2,320.22
-3,994.79
-5,682.81
-3,979.05
-7,847.37
-355.2
-215.2
-4,597.2
-198.06
-162.04
-650.97
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-4
-2
-2
-4
-4
-4
-4
-6
-3
-4
-32
-6
-9
-10
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-30,592.86
-278.89
-134.4
-2,386.89
-4,015.62
-5,723.44
-3,450.48
-8,430.26
-364.91
-251.16
-4,963.04
-214.26
-174.29
-696.9
- -
Profit Margin (%)
- -
3
3
7
3
- -
5
-3
-4
- -
-3
-6
- -
-7
-2
Working Capital
- -
- -
- -
- -
- -
- -
- -
2
1
- -
1
1
- -
- -
- -
LT Debt
- -
2
2
6
2
-2
7
2
- -
1
-2
-6
1
-7
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-128.84
-113.06
-100.27
- -
- -
-137.76
-264.52
-815.2
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
14

Working Capital

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
3
2
4
Cash, Cash Equivalents & STI
- -
- -
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
9
5
Payables & Accruals
- -
- -
- -
ST Debt
- -
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-255.47%
-322.02%
-1,198.76%
Free Cash Flow
14.72%
33.58%
-48.9%
Net Income, GAAP
65.93%
130.32%
14.34%
Sales/Revenue/Turnover
137.23%
78.34%
-71.41%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
5
2025
- -
- -
1
2026
- -
- -
- -

Semi-annual Earnings Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-32.86
2025
- -
- -
-28.15
2026
- -
- -
- -

Semi-annual Dividends Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Silver Castle Holdings Ltd (SLCL.TA) engages in digital asset investment activities and provides institutional-grade investment management services focused on cryptocurrencies and blockchain-based financial products. The company offers bitcoin-backed bonds; asset and investment management services; advanced trading strategies for managing digital currency investments; and structured products including SCL Momentum Alpha, SCL Advanced Strategies, and SCL SmartETH, which combine risk management, algorithmic trading, and exposure to digital assets such as ETH. It operates primarily in Israel, serving a range of investors through secure access to digital markets, and maintains headquarters at 45 Rothschild Street, Tel Aviv, Israel, where it was founded in 1999. Silver Castle Holdings Ltd collaborates with regulators on innovative financial frameworks for digital assets and partners with media entities such as Keshet for promotional campaigns targeting digital asset investments. Formerly known as Israel China Biotechnology (ICB) Ltd, the company underwent a strategic pivot and name change to Silver Castle Holdings Ltd in February 2022, followed by its listing as a publicly traded entity on the Tel Aviv Stock Exchange in January 2022. These changes marked its transition from biotechnology to a focus on digital assets, with ongoing development of algorithmic trading and investment solutions amid the evolving cryptocurrency sector.